How Stockholm-Uppsala is keeping global infections at bay
Invest Stockholm invites you to a webinar on how Stockholm-Uppsala has emerged as a global leader in infection control. Anders Blanck, Director-general at Lif is participating.
Invest Stockholm has mapped more than 110 companies, specializing in this field, in addition to successful research groups. At this webinar you will meet three of them – Gradientech, Svenska Vaccinfabriken Produktion and Molecular Attraction. Also key opinion leader Anders Blanck, CEO Swedish Association of the Pharmaceutical Industry, will share his expertise perspectives.
Many challenges face the world today, but few are quite as universal as the threat of infections. The success in the sector is to a great extent thanks to the strong profile in life sciences in the Stockholm-Uppsala region: four leading universities and a world-class research hospital enable close collaboration between laboratory scientists and physicians. Together they present a unique opportunity for clinical development.
Date: March 30th 2022
Platform: Zoom (link will be received after registration)
Time: 9-10 CET
Program
09.00 Welcome and introduction, Anna Gissler, CEO Invest Stockholm
09.05 Executive summary, Ylva Hultman, Business Development Manager, Life Science Invest Stockholm
09.10 Key Opinion Leader, Anders Blanck CEO, the Swedish Association of the Pharmaceutical Industry
09.25 Sara Torslund, CEO Gradientech AB
09.35 Jens Beck, CEO Svenska Vaccinfabriken Produktion AB
09.45 Lech Ignatowicz, CEO Molecular Attraction